Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Effectiveness of Pet-Robotic Intervention in Intensive Care Unit Patients

Effectiveness of Using Pet-Robotic Intervention to Enhance Spontaneous Breathing Trial Success in Intensive Care Unit Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study aims to develop a novel nursing intervention involving robotic pet companionship to reduce anxiety in patients undergoing spontaneous breathing trials.

Who May Be Eligible (Plain English)

Who May Qualify: - Aged 18 years or older with clear consciousness. - Mechanical ventilation for more than 72 hours. - Previously failed the first spontaneous breathing trial and is clinically ready to undergo a second spontaneous breathing trial. Who Should NOT Join This Trial: - Multidrug-resistant organism infection. - Requiring airborne infection isolation precautions (e.g., COVID-19). - weakened immune system (absolute neutrophil count \< 500 cells/mL). - Richmond Agitation-Sedation Scale (RASS) less than -1. - Patient with a tracheostomy. - Subjects with implanted cardiac devices (e.g., permanent pacemaker, implantable cardioverter defibrillators) - Known allergy to the fur of the robotic pet. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Aged 18 years or older with clear consciousness. * Mechanical ventilation for more than 72 hours. * Previously failed the first spontaneous breathing trial and is clinically ready to undergo a second spontaneous breathing trial. Exclusion Criteria: * Multidrug-resistant organism infection. * Requiring airborne infection isolation precautions (e.g., COVID-19). * Immunodeficiency (absolute neutrophil count \< 500 cells/mL). * Richmond Agitation-Sedation Scale (RASS) less than -1. * Patient with a tracheostomy. * Subjects with implanted cardiac devices (e.g., permanent pacemaker, implantable cardioverter defibrillators) * Known allergy to the fur of the robotic pet.

Treatments Being Tested

BEHAVIORAL

Robotic pet (PARO) companionship

The intervention is composed of the following components: Duration: Robotic pet companionship lasting 30-120 minutes, depending on clinical goals during each spontaneous breathing trial (SBT). Preparation and interaction: PARO is introduced 30 minutes before each SBT to establish emotional connection. Study staff will briefly introduce its interactive features, including responding to stroking, gentle tapping, head movements, and eye blinking. Participants may interact freely with PARO during the intervention. Assessment: Outcome measurements are conducted during the intervention. If extubated successfully, a semi-structured interview is conducted three days later. Early termination: The intervention is stopped if the participant becomes clinically unsuitable for further SBTs or experiences a serious adverse event (e.g., device dislodgement). Additional information: After each SBT, PARO is sterilized and stored in a sealed container in the patient's room.

Locations (1)

National Taiwan University Hospital
Taipei, Taiwan